Cost‐Effectiveness of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea‐Hypopnea in British Columbia
Author(s) -
MCY Tan,
NT Ayas,
Alan Mulgrew,
Lisa Cortes,
J Mark FitzGerald,
JA Fleetham,
Michael Schulzer,
C. Francis Ryan,
Reza Ghaeli,
P Cooperx,
Carlo A. Marra
Publication year - 2008
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2008/719231
Subject(s) - medicine , obstructive sleep apnea , continuous positive airway pressure , hypopnea , airway , positive airway pressure , sleep (system call) , sleep disordered breathing , apnea , anesthesia , sleep apnea , polysomnography , intensive care medicine , computer science , operating system
Obstructive sleep apnea-hypopnea (OSAH) is a common disorder characterized by recurrent collapse of the upper airway during sleep. Patients experience a reduced quality of life and an increased risk of motor vehicle crashes (MVCs). Continuous positive airway pressure (CPAP), which is the first-line therapy for OSAH, improves sleepiness, vigilance and quality of life.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom